CUSHING'S SYNDROME DUE TO ADRENAL CORTICAL CARCINOMA by 菅野, 理 et al.
Title Cushing症候群を呈した副腎皮質癌の1例
Author(s)菅野, 理; 沼沢, 和夫; 川村, 俊三














   理
和  夫
俊  ．三
CUSHING’S SYNDROME DUE TO ADRENAL CORTICAL CARCINOMA
   Osamu SuGANo， Kazuo NuMAsAwA and Shunzo KAwAMuRA
Fr・m theエ）ePartmentげ研・♂・9ク， y珈α9α’αUniver5t’tv Sch・・1・f Medicine y吻α9α彦α，ノ吻π．
             （Direetor： Prof． K． Suzuki）
  We report a case ef adrenal cortical carcinoma presenting signs of Cushing’s syndrome．
  The patient was a 56－year－old housewife． She was hospitalized on November 14， 1979， with
the chief complaints of headache， obesity， and hypertension． She had had these chief complaints
for two years， but had not received any treatment．
  No cvident伽dings of distant metastasis were obtained by the preoperative examination’． The
patient received left adrenalectomy on December 10， 1979． Histologically， the case was carcinoma
of the adrenal cortex composed of clear cells and compact cells， and had advanced to stage 3． Six
months later， o，p’一DDD was administered to treat the recurrence and metastasis ofthe cancer． Therapy
was ineffective， and the patient died on February 2， 1981．
  At present， o，p’一DPD is used only in inoperable cases． lt seems． necessary， however， to investigate
its value as a means of preventing recurrence．































546 泌尿紀要 28巻 5号 1982年
Table 1．初回入院時，手術後，再入院時のそれぞれの内分泌学時検査結果． （）正常値を示す

















454 ng／ml ・ 1．3”g／dl










































“ O．9一一 62．7 ）
4．01ng／m 1／h
（Q5一一2．0）
       542．ONg／24 h
       （50’一［Z6｝
       17． Ipg／24h
       （Q9－9，0）
       1 23．6Ng／24 h











 検査成績；血液検査：WBC 5，900／mm3， RBG 3．88
×106／mm3， Hb 8．5 g／dl， Ht 28．1％， ESR 10－7 mm
2“一 15 mm，生化学検査．：TP 6．29／dl， Alb 65．8％，
cri－Gl・ 2．6％， a2－Gl． 10．4％， P－Gl． IO．3％， r－GI． 11．0
％， GOT 14u， GPT 4 u， LDH 284 u， Al－P 180u， r－
GTP 94u， BUN 20 mg／dl， Cr 1．O mg／dl， Na 144
mEq／L， K 8．3 rnEq／L， Cl 106 mEq／L， FBS 98 mg／








































































































































































ちstage 1は1例のみ， stage 2も5例であるのに対
しstage 3が9例， stage 4が13例であり，進行例が
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圧倒的に多くみられたと報告し，同様に．Didolkarら5）
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